BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 17297405)

  • 1. Immunomodulatory properties of FK734, a humanized anti-CD28 monoclonal antibody with agonistic and antagonistic activities.
    Shiao SL; McNiff JM; Masunaga T; Tamura K; Kubo K; Pober JS
    Transplantation; 2007 Feb; 83(3):304-13. PubMed ID: 17297405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The capacity of the natural ligands for CD28 to drive IL-4 expression in naïve and antigen-primed CD4+ and CD8+ T cells.
    Bian Y; Hiraoka S; Tomura M; Zhou XY; Yashiro-Ohtani Y; Mori Y; Shimizu J; Ono S; Dunussi-Joannopoulos K; Wolf S; Fujiwara H
    Int Immunol; 2005 Jan; 17(1):73-83. PubMed ID: 15569772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenicity of biliary epithelium: investigation of antigen presentation to CD4+ T cells.
    Leon MP; Bassendine MF; Wilson JL; Ali S; Thick M; Kirby JA
    Hepatology; 1996 Sep; 24(3):561-7. PubMed ID: 8781325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumour necrosis factor-alpha chimeric antibody (infliximab) inhibits activation of skin-homing CD4+ and CD8+ T lymphocytes and impairs dendritic cell function.
    Bedini C; Nasorri F; Girolomoni G; Pità Od; Cavani A
    Br J Dermatol; 2007 Aug; 157(2):249-58. PubMed ID: 17489975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis.
    Hombach A; Sent D; Schneider C; Heuser C; Koch D; Pohl C; Seliger B; Abken H
    Cancer Res; 2001 Mar; 61(5):1976-82. PubMed ID: 11280755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A model of human anti-T-cell monoclonal antibody therapy in SCID mice engrafted with human peripheral blood lymphocytes.
    Tsuchida M; Brown SA; Tutt LM; Tan J; Seehafer DL; Harris JP; Xun CQ; Thompson JS
    Clin Transplant; 1997 Oct; 11(5 Pt 2):522-8. PubMed ID: 9361954
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intestinal epithelial cells from inflammatory bowel disease patients preferentially stimulate CD4+ T cells to proliferate and secrete interferon-gamma.
    Dotan I; Allez M; Nakazawa A; Brimnes J; Schulder-Katz M; Mayer L
    Am J Physiol Gastrointest Liver Physiol; 2007 Jun; 292(6):G1630-40. PubMed ID: 17347451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of CD86/CD28 and CD40/CD154 pathways in regulating monocyte-derived CD80 expression during their interaction with allogeneic endothelium.
    Wang P; Liu Z; Wu C; Zhu B; Wang Y; Xu H
    Transplant Proc; 2008 Oct; 40(8):2729-33. PubMed ID: 18929847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal allograft rejection. Tubular epithelial cells present alloantigen in the presence of costimulatory CD28 antibody.
    Wilson JL; Proud G; Forsythe JL; Taylor RM; Kirby JA
    Transplantation; 1995 Jan; 59(1):91-7. PubMed ID: 7530869
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human myeloid dendritic cells transduced with an adenoviral interleukin-10 gene construct inhibit human skin graft rejection in humanized NOD-scid chimeric mice.
    Coates PT; Krishnan R; Kireta S; Johnston J; Russ GR
    Gene Ther; 2001 Aug; 8(16):1224-33. PubMed ID: 11509955
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD28 costimulation provided through a CD19-specific chimeric antigen receptor enhances in vivo persistence and antitumor efficacy of adoptively transferred T cells.
    Kowolik CM; Topp MS; Gonzalez S; Pfeiffer T; Olivares S; Gonzalez N; Smith DD; Forman SJ; Jensen MC; Cooper LJ
    Cancer Res; 2006 Nov; 66(22):10995-1004. PubMed ID: 17108138
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory effects of antihistamines on the responses to staphylococcal enterotoxin B of human monocyte-derived dendritic cells and CD4+ T cells.
    Iida H; Asada H; Yokoi S; Niizeki H; Yasuda Y; Miyagawa S; Kita E
    J Dermatol Sci; 2008 Oct; 52(1):31-8. PubMed ID: 18524543
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-inflammatory effects of Artemisia princeps in antigen-stimulated T cells and regulatory T cells.
    Chang SH; Jung EJ; Park YH; Lim DG; Ko NY; Choi WS; Her E; Kim SH; Choi KD; Bae JH; Kim SH; Kang CD; Han DJ; Kim SC
    J Pharm Pharmacol; 2009 Aug; 61(8):1043-50. PubMed ID: 19703348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation.
    Tse WT; Pendleton JD; Beyer WM; Egalka MC; Guinan EC
    Transplantation; 2003 Feb; 75(3):389-97. PubMed ID: 12589164
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human regulatory CD8 T cells.
    Ablamunits V; Bisikirska BC; Herold KC
    Ann N Y Acad Sci; 2008 Dec; 1150():234-8. PubMed ID: 19120302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of antigen-specific T cell response by a non-mitogenic anti-CD3 antibody.
    Li J; Davis J; Bracht M; Carton J; Armstrong J; Gao W; Scallon B; Fung R; Emmell E; Zimmerman M; Griswold DE; Li L
    Int Immunopharmacol; 2006 Jun; 6(6):880-91. PubMed ID: 16644473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interleukin-12 can replace CD28-dependent T-cell costimulation during nonspecific cytotoxic T lymphocyte induction by anti-CD3 antibody.
    Makrigiannis AP; Musgrave BL; Haeryfar SM; Hoskin DW
    J Leukoc Biol; 2001 Jan; 69(1):113-22. PubMed ID: 11200055
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelial inducible costimulator ligand expression is increased during human cardiac allograft rejection and regulates endothelial cell-dependent allo-activation of CD8+ T cells in vitro.
    Klingenberg R; Autschbach F; Gleissner C; Giese T; Wambsganss N; Sommer N; Richter G; Katus HA; Dengler TJ
    Eur J Immunol; 2005 Jun; 35(6):1712-21. PubMed ID: 15864782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CTLA4-CD80/CD86 interactions on primary mouse CD4+ T cells integrate signal-strength information to modulate activation with Concanavalin A.
    Mukherjee S; Ahmed A; Nandi D
    J Leukoc Biol; 2005 Jul; 78(1):144-57. PubMed ID: 15788440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.